Faraz Ali
About Faraz Ali
Title: Chief Executive Officer
Faraz Ali serves as the Chief Executive Officer. His career trajectory includes significant executive roles across various biotech and healthcare companies. These roles have provided him with extensive experience in corporate leadership and strategic business development.
Career at REGENXBIO
Faraz Ali was most recently the Chief Business Officer at REGENXBIO. In this role, he had accountability for corporate development, commercial planning, portfolio strategy, alliance management, and corporate communications. His work at REGENXBIO focused on expanding the company's reach and operational effectiveness in the biotech industry.
Professional Experience at bluebird bio
At bluebird bio, Faraz Ali served as a Vice President, where he was responsible for new product planning, program management, patient advocacy, and external affairs. His leadership helped advance bluebird bio's strategic initiatives and reinforced its commitment to patient-centric approaches and innovative product development.
Tenure at Genzyme Corporation
Faraz Ali held roles of increasing global commercial leadership at Genzyme Corporation. Notably, he contributed to the launch of multiple first-in-class enzyme replacement therapies for rare diseases. His work at Genzyme emphasized his capability in leading commercial strategies and executing successful product launches.
Educational Background
Faraz Ali earned an MBA from Harvard Business School, equipping him with advanced business management and strategic planning skills. He also holds a B.S. from Stanford University, providing a strong foundation in technical and analytical disciplines.
Early Career at General Electric
Faraz Ali started his career at General Electric, where he held technical roles at GE Healthcare and business assignments at GE Corporate. This early experience at a major corporation provided him with a broad understanding of both technical and business aspects of the healthcare industry.
Board Appointment at The Alliance for Regenerative Medicine (ARM)
In 2022, Faraz Ali was appointed to the Board of Directors for The Alliance for Regenerative Medicine (ARM). This role allows him to contribute to the governance and strategic direction of ARM, furthering its mission to advocate for the regenerative medicine sector.